Browse “Bevacizumab” in an alphabetical list of subjects

Browse by subject help: Search within an alphabetical list of all Library of Congress Subject Headings - Opens in new windowopen_in_new (LCSH) indexed in the Library catalog.

Subject Records
Subject:
Beuzeville-au-Plain (Château : France) 1 record
1 record
Subject:
Beuzeville (France) 1 record
1 record
We found a matching subject in our catalog for: Bevacizumab.
Subject:
Bevacizumab About this subject - Opens in new windowopen_in_new 1 record
Broader terms (in subject list):
  1. Antineoplastic agents (183 records)
  2. Monoclonal antibodies (93 records)
  3. Vascular endothelial growth factors--Antagonists (2 records)
1 record
Subject:
Bevagna (Italy) 1 record
1 record
Subject:
Bevagna (Italy)--Description and travel 1 record
1 record
Subject:
Bevagna (Italy)--History--Sources 1 record
1 record
Subject:
Bevaix-le Bataillard Site (Switzerland) About this subject - Opens in new windowopen_in_new 0 records
Broader term (in subject list):
  1. Switzerland--Antiquities (78 records)
0 records
Subject:
Bevan, Aneurin, 1897-1960 15 records
15 records
Subject:
Bevan, Aneurin, 1897-1960--Marriage 1 record
1 record
Subject:
Bevan, Bridget 1 record
1 record
Subject:
Bevan, Charles, 1778-1811 1 record
1 record
Subject:
Bevan, Donald--Film adaptations 1 record
1 record
Subject:
Bevan, Donald--Television adaptations 1 record
1 record
Subject:
Bevan, Evan, 1678?-1746 1 record
1 record
Subject:
Bevan, Joseph 1 record
1 record
Subject:
Bevan, Joseph Gurney, 1753-1814 1 record
1 record
Subject:
Bevan, Joseph Vallence, 1798-1830 1 record
1 record
Subject:
Bevan, Lynne 1 record
1 record
Subject:
Bevan, Lynne John, editor 1 record
1 record
Subject:
Bevan, Mark 1 record
1 record

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Give feedback about this page - Opens in new windowopen_in_new